SLC20A1
| Symbol | SLC20A1 |
|---|---|
| HGNC ID | 10915 |
| Alternative symbols | – |
| Entrez Gene | 6574 |
| OMIM | 158378 |
| RefSeq | NM_005415 |
| UniProt | Q8WUM9 |
| Chromosome | 2q14 |
| Locus supplementary data | – |
SLC20A1 is a gene that encodes a protein known as the sodium-dependent phosphate transporter 1 (PiT-1). This protein is involved in the transport of phosphate ions across cell membranes, which is crucial for various cellular functions including metabolism, signal transduction, and nucleic acid synthesis.
Function
The SLC20A1 gene product, PiT-1, is a type III sodium-dependent phosphate transporter. It plays a significant role in maintaining phosphate homeostasis in the body. Phosphate is essential for bone mineralization, energy storage and release, and the regulation of acid-base balance in the body.
Clinical Significance
Mutations or dysregulation of the SLC20A1 gene can lead to disorders related to phosphate metabolism. Abnormal phosphate levels can result in conditions such as hyperphosphatemia or hypophosphatemia, which can affect bone health and lead to osteoporosis or rickets.
Expression
SLC20A1 is expressed in a wide range of tissues, indicating its fundamental role in cellular physiology. It is particularly important in tissues with high phosphate turnover, such as the kidney, intestine, and bone.
Interactions
The PiT-1 protein interacts with various other proteins and molecules to facilitate phosphate transport. It is regulated by factors such as parathyroid hormone and fibroblast growth factor 23 (FGF23), which are involved in phosphate homeostasis.
Research
Ongoing research is focused on understanding the precise mechanisms by which SLC20A1 regulates phosphate transport and its implications in disease states. Studies are also exploring potential therapeutic targets for conditions resulting from phosphate imbalance.
See Also
References
External Links
| Genes on human chromosome 2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD